Li-Xia Du (Lixia Du)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Neuropathic Pain

Top Venues

ACS chemical neuroscience

Science signaling

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Xinyi Gao, Zhifei Wang, Li-Xia Du
Glial Cells and Itch: Possible Targets for Novel Antipruritic Therapies. ACS chemical neuroscience 14 (3) (2023)
Xinyi Gao, Zhifei Wang, Li-Xia Du
Glial Cells and Itch: Possible Targets for Novel Antipruritic Therapies. ACS chemical neuroscience 14 (3) (2023)
Xinyi Gao, Zhifei Wang, Li-Xia Du
Glial Cells and Itch: Possible Targets for Novel Antipruritic Therapies. ACS chemical neuroscience (2023)
Xinyi Gao, Zhifei Wang, Li-Xia Du
Glial Cells and Itch: Possible Targets for Novel Antipruritic Therapies. ACS chemical neuroscience 14 (3) (2023)
Xue-Ming Hu, Wei Yang, Meng-Ting Zhang, Li-Xia Du, Jia-He Tian, Jian-Yu Zhu, Yu Chen, Feng Hai, Shen-Bin Liu, Qi-Liang Mao-Ying, Yu-Xia Chu, Hong Zhou, Yan-Qing Wang, Wen-Li Mi
Glial IL-33 signaling through an ST2-to-CXCL12 pathway in the spinal cord contributes to morphine-induced hyperalgesia and tolerance. Science signaling 14 (699) (2021)
Zhou Lan, Lvyi Chen, Jing Feng, Zili Xie, Zhiyong Liu, Fang Wang, Peng Liu, Xueping Yue, Li-Xia Du, Yonghui Zhao, Pu Yang, Jialie Luo, Zhe Zhu, Xueming Hu, Liang Cao, Ping Lu, Rajan Sah, Kory Lavine, Brian Kim, Hongzhen Hu
Mechanosensitive TRPV4 is required for crystal-induced inflammation. Annals of the rheumatic diseases 80 (12) (2021)